Article type
Abstract
"Background: Diabetes management programs (DMP) could help patients with diabetes fully understand the disease, maintain a healthy lifestyle, keep the illness under control and provide psychosocial support, therefore improve the disease prognosis. We conducted a systematic survey to evaluate the effectiveness of DMP on patients with diabetes and their perceptions of diseases.
Methods: Eligible articles were searched in three databases from their inception to November 2023. Only mixed method studies evaluating the effectiveness of DMP and integrating perceptions of participants were considered. The JBI critical appraisal tools were used for quality appraisal. The convergent segregated approach was used to synthesize and integrate quantitative and qualitative data.
Results: Twenty-nine mixed method studies were included. The quantitative evidence showed that DMP could clinically decrease haemoglobin A(1c) (HbA1c), blood pressure levels, triglyceride, and body mass index outcomes (P > 0.05). The DMP had a significantly better effect on total cholesterol than the control group (P < 0.05). The decreasing trends of HbA1c in the DMP group were more evident with the extension of time (3 months: WMD = -0.39, 95% CI: -1.02 to 0.23, P = 0.22; 6 months: WMD = -0.51, 95% CI: -1.08 to 0.05, P = 0.08; 12 months: WMD = -0.06, 95% CI: -0.93 to 0.81, P = 0.002). Qualitative data were synthesized to these categories: attitudes towards DMP, health literacy and understanding of diabetes, psychological outcomes, health behaviors, information sharing and interactive support, barriers, and areas to improve. Participants with DMP could have better understanding of diabetes, improve psychological outcomes, maintain healthy lifestyle, and summarize barriers and improvements, which complemented the qualitative results.
Conclusions: The DMP intervention is effective for patients with diabetes, and contributes to the understanding, perceptions of barriers and improvement, providing evidence for decision-making in diabetes management."
Methods: Eligible articles were searched in three databases from their inception to November 2023. Only mixed method studies evaluating the effectiveness of DMP and integrating perceptions of participants were considered. The JBI critical appraisal tools were used for quality appraisal. The convergent segregated approach was used to synthesize and integrate quantitative and qualitative data.
Results: Twenty-nine mixed method studies were included. The quantitative evidence showed that DMP could clinically decrease haemoglobin A(1c) (HbA1c), blood pressure levels, triglyceride, and body mass index outcomes (P > 0.05). The DMP had a significantly better effect on total cholesterol than the control group (P < 0.05). The decreasing trends of HbA1c in the DMP group were more evident with the extension of time (3 months: WMD = -0.39, 95% CI: -1.02 to 0.23, P = 0.22; 6 months: WMD = -0.51, 95% CI: -1.08 to 0.05, P = 0.08; 12 months: WMD = -0.06, 95% CI: -0.93 to 0.81, P = 0.002). Qualitative data were synthesized to these categories: attitudes towards DMP, health literacy and understanding of diabetes, psychological outcomes, health behaviors, information sharing and interactive support, barriers, and areas to improve. Participants with DMP could have better understanding of diabetes, improve psychological outcomes, maintain healthy lifestyle, and summarize barriers and improvements, which complemented the qualitative results.
Conclusions: The DMP intervention is effective for patients with diabetes, and contributes to the understanding, perceptions of barriers and improvement, providing evidence for decision-making in diabetes management."